AIMP2-DX2 gene and SiRNA targeting AIMP2-DX2
US8003780B2 · kind B2 · utility
92Cited by
2References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 22, 2008 |
| Grant date | Aug 23, 2011 |
| Priority date | — |
| Expiry date | Oct 22, 2028 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2500/04
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention relates to a variant of AIMP2 lacking exon 2 gene, named as AIMP2-DX2 gene, which is specifically expressed in cancer cells. The AIMP2-DX2 gene and siRNA targeting AIMP2-DX2 can be successfully used in the development of diagnosis and treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.